NDC 70842-102-01 - Baxdela
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70842-102
- Requested NDC
- 70842-102-01
- Package NDCs from labels
- 70842-102-01, 70842-102-03
- Manufacturer
- Melinta Therapeutics, LLC | SGS North America Inc. | ScinoPharm Taiwan, Ltd. | Pharma Packaging Solutions, LLC dba Tjoapack, LLC | Bostal LLC
- Effective date
- 2025-08-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Baxdela | Melinta Therapeutics, LLC | SGS North America Inc. | ScinoPharm Taiwan, Ltd. | Pharma Packaging Solutions, LLC dba Tjoapack, LLC | Bostal LLC | 2025-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70842-102-01 | Baxdela | 10.5 mL in 1 VIAL, GLASS | INJECTION, POWDER, LYOPHILIZED, | 10.5 | 21 | |
| 70842-102-03 | Baxdela | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 21 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70842-102 | BAXDELA (DELAFLOXACIN MEGLUMINE) TABLET BAXDELA (DELAFLOXACIN MEGLUMINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MELINTA THERAPEUTICS, LLC] | 20 | Current NDC, Legacy NDC, 2 package rows | 20250426_fb77637a-88d9-4aea-958f-e270030ce30d.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70842-102-01 | EA - Each | 70842-102 | 4c6adc42-a7ff-4774-ba33-4c952b6bfe31 | 1 | 2022-06-06 |
| 70842-102-03 | EA - Each | 70842-102 | f6f1fed3-cc93-4382-97c6-565d39abe6b1 | 1 | 2017-10-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| QUABIC-300 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | c3cd7f0f-8d70-23af-e053-2a95a90a569b | 2025-11-10 | Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Henry Schein, Inc. | da484a2f-154f-48b4-8467-7a86729204c3 | 2025-11-07 | Warnings, Adverse reactions | 8MDF5V39QO |
| STERILE WATER | WATER | Henry Schein, Inc. | f4087143-9868-4308-b96c-43657ee8ec28 | 2025-11-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | ea20a5eb-641e-48cd-bcfa-74c04c45dfda | 2025-11-06 | Warnings, Adverse reactions | 8MDF5V39QO |
| CEO-TWO | LAXATIVE | Beutlich Pharmaceuticals, LLC | 08670636-5795-4db0-e063-6294a90afa4b | 2025-11-05 | Warnings | 8MDF5V39QO |
| Omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Walgreen Company | 8753a131-f8b1-48e1-993b-73c1ee635fef | 2025-11-04 | Warnings | 8MDF5V39QO |
| Bacteriostatic Water | BACTERIOSTATIC WATER | ProPharma Distribution | 42c6938e-f747-ae13-e063-6294a90a59a3 | 2025-11-04 | Warnings, Adverse reactions | 059QF0KO0R |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | CVS Pharmacy | 186732a3-13b9-4ea2-ba54-424f63298a2e | 2025-11-04 | Warnings | 8MDF5V39QO |
| basic care omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Amazon.com Services LLC | 4587f491-04ef-4c31-b7b6-bfafd31776fb | 2025-11-04 | Warnings | 8MDF5V39QO |
| Omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | H E B | ddc8d73f-f4a1-42a7-89ee-420346820f61 | 2025-11-03 | Warnings | 8MDF5V39QO |
| Sterile Water | WATER | ICU Medical Inc. | aab10f03-26ae-4dbc-a481-ef025e48b405 | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | e3484bc6-ed7f-43ef-9d49-c131a8dff2dd | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Ionosol MB and Dextrose | DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ICU Medical Inc. | 1b457b1d-0e80-4578-ba6f-dedf513fc962 | 2025-10-30 | Warnings, Adverse reactions | 593YOG76RN |
| Sterile Water | WATER | ICU Medical Inc. | 1c0bbcb7-5ed6-4ee7-b297-080d3359474e | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2025-10-27 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | Becton Dickinson and Company | cab03cda-4660-4020-a3be-bf86242ff664 | 2025-10-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Me NaPhos MB Hyo 1 | URINARY ANTISEPTIC ANTISPASMODIC | Method Pharmaceuticals | 2ae628e7-3b33-6a9a-e054-00144ff8d46c | 2025-10-21 | Warnings, Adverse reactions | 593YOG76RN |
| Walgreens Antacid Pain Relief Extra Strength | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walgreens | b60df498-07db-500b-e053-2a95a90aff6a | 2025-10-17 | Warnings | XF417D3PSL 8MDF5V39QO |
| Equate Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walmart | 6271b34b-55a0-40a8-e053-2a91aa0acb22 | 2025-10-17 | Warnings, Adverse reactions | XF417D3PSL 8MDF5V39QO |
| EQUATE SALINE PACKETS | NASAL CLEANING SALT | WALMART INC | 9e905ecb-d4d5-514a-e053-2a95a90adfbb | 2025-10-08 | Warnings | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.